Skip to content

Effect of Psyllium seed on the gastric reflux in patients with constipation

The Comparison of the effect of Psyllium seed on the resolution and recurrence of Gastroesophageal Reflux Disease (GERD) with oral omeprazole in patients with functional constipation: A Randomized Clinical Trial study

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015040315122N2
Enrollment
132
Registered
2015-10-26
Start date
2015-02-28
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastro-esophageal reflux disease. Gastro-esophageal reflux disease with esophagitis

Interventions

Intervention 1: Psyllium: The population treated with psyllium will be given 5 mg of the bulking agent solved in hot tap water one hour before breakfast and dinner with a goal of bowel movements and a
Treatment - Drugs
Psyllium: The population treated with psyllium will be given 5 mg of the bulking agent solved in hot tap water one hour before breakfast and dinner with a goal of bowel movements and a complete sense
Omeprazole: The omeprazole group will receive twenty-milligram omeprazole capsules half an hour before breakfast and dinner.

Sponsors

Vice chancellor for research, Mashad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Symptomatic patients with minimum three years history of gastroesophageal reflux disease and functional constipation whose esophagitis in upper endoscopy will be confirmed. Exclusion criteria: History of or current gastrointestinal cancer; Hiatal hernia; Irritable bowel syndrome; Endocrine diseases (e.g., hypothyroidism); Drug-induced constipation; Psychological disorders; Cardiovascular diseases; Liver diseases; Renal diseases; Opiums abuse

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Assessment reflux disease remission with constipation improvement. Timepoint: First day, 7th day, 14th day, 21th day, 28th day, 35th day,42th day, 49th day and 56th day after intervention. Method of measurement: History of heart burn and regurgitation(clinical symptoms of GERD) was taken. Then the visual scale was used for evaluation.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMasoumeh Salari

Mashhad University Of Medical Sciences

salarim@mums.ac.ir+98 51 3801 2742

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026